chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe ache in all  joints and muscles from torso to lower limbs; lethargy; weakness.  No elevation of temperature. No nausea, vomiting, but definite loss of appetite.
Initial report was received on 29 September 2011 from a health care professional. A two-month-old male patient, had received on 24 September 2011 an intramuscular left thigh injection of PENTACEL, lot number C3853AA and an intramuscular right thigh injection of PREVNAR13, Pfizer lot number 916304 and two hours later, the patient began vomiting profusely and vomiting with each feeding. The patient was taken to the ER (emergency room) and was diagnosed with mild dehydration. She was treated with an "IV" (intravenous) not otherwise specified. The patient had not experienced any adverse events following prior vaccinations. No further information was available at the time of the report. The patient's outcome was recovered (date not reported). Follow-up information was received on 27 December 2011 from health care professional. The patient was diagnosed with a UTI (urinary tract infection). According to the reporter, there was no adverse RXN (reaction). Documents held by sender: none.
Nosebleed started around a week later; Has not had second shot  >36 days between doses; fiery prickles over my body/all over my skin, similar to niacin flush; Dizzy; Heart rate, it was through the roof; Short of breath/couldn't catch my breadth; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (fiery prickles over my body/all over my skin, similar to niacin flush), DIZZINESS (Dizzy), HEART RATE INCREASED (Heart rate, it was through the roof), DYSPNOEA (Short of breath/couldn't catch my breadth) and EPISTAXIS (Nosebleed started around a week later) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced PARAESTHESIA (fiery prickles over my body/all over my skin, similar to niacin flush), DIZZINESS (Dizzy), HEART RATE INCREASED (Heart rate, it was through the roof), DYSPNOEA (Short of breath/couldn't catch my breadth) and PRODUCT DOSE OMISSION ISSUE (Has not had second shot  >36 days between doses). On an unknown date, the patient experienced EPISTAXIS (Nosebleed started around a week later). At the time of the report, PARAESTHESIA (fiery prickles over my body/all over my skin, similar to niacin flush), DIZZINESS (Dizzy), HEART RATE INCREASED (Heart rate, it was through the roof), DYSPNOEA (Short of breath/couldn't catch my breadth) and EPISTAXIS (Nosebleed started around a week later) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (Has not had second shot  >36 days between doses) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided Treatment information was not reported
Arm in constant pain. "It doesn't go away". Unable to sleep on arm. Ices arm to sleep. "Once I lay down, it becomes a pulsating pain". Pt saw general practitioner about arm twice within the last 8 wks, and GP put pt on a magnesium supplement. Also uses Biofreeze ointment and Voltaran gel, which provides temporary relief.
Monday morning mom noticed raised rash to chest-upper thighs (both) Ant and posteriorly. Also to upper back. Child cranky all weekend with temp of 100 AX. No vomiting, diet taken well, active.
Felt foggy; slight headache; Chills; fatigue; itchiness on arms; stomach bloating; bumps on arms; sensitive, slightly swollen bottom lip; sensitive, slightly swollen bottom lip; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchiness on arms), ABDOMINAL DISTENSION (stomach bloating), PERIPHERAL SWELLING (bumps on arms), LIP PAIN (sensitive, slightly swollen bottom lip) and LIP SWELLING (sensitive, slightly swollen bottom lip) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Waldenstrom's macroglobulinaemia since an unknown date. Concurrent medical conditions included Drug allergy (Levaquin), Drug allergy (Bacitricin), Drug allergy (Z pack,), Drug allergy (Codeine), Penicillin allergy and . Concomitant products included RITUXIMAB (RITUXAN), CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) from 01-Jan-2019 to an unknown date, ROSUVASTATIN CALCIUM (CRESTOR) from 10-Jan-2020 to an unknown date, CLINDAMYCIN from 01-Jan-2015 to an unknown date and SERTRALINE HYDROCHLORIDE (ZOLOTRIN) for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced PRURITUS (itchiness on arms), ABDOMINAL DISTENSION (stomach bloating), PERIPHERAL SWELLING (bumps on arms), LIP PAIN (sensitive, slightly swollen bottom lip) and LIP SWELLING (sensitive, slightly swollen bottom lip). On an unknown date, the patient experienced FEELING ABNORMAL (Felt foggy), HEADACHE (slight headache), CHILLS (Chills) and FATIGUE (fatigue). The patient was treated with CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) at an unspecified dose and frequency. At the time of the report, PRURITUS (itchiness on arms), ABDOMINAL DISTENSION (stomach bloating), PERIPHERAL SWELLING (bumps on arms), LIP PAIN (sensitive, slightly swollen bottom lip) and LIP SWELLING (sensitive, slightly swollen bottom lip) had not resolved and FEELING ABNORMAL (Felt foggy), HEADACHE (slight headache), CHILLS (Chills) and FATIGUE (fatigue) outcome was unknown. Not Provided          Patient had same reactions with Levaquin, Bacitracin, Flu  shot(1 time) and Tetanus/MMR Vaccine.   This case was linked to MOD-2021-114869, MOD-2021-114869 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Additional information received
Migraine; Sore arm; Began to feel weak; Foggy headed/foggy headedfeeling; feel even more tired./ I still struggle with fatigue; Vertigo; Dizziness; Joint pain; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 08Apr2021 at 13:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included liver hemangioma and acid reflux. Patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included omeprazole (PRILOSEC) and multivitamin (MANUFACTURER UNKNOWN); both from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, within 5 minutes of receiving the vaccine, the patient began to feel weak and foggy headed, later on the day she had a sore arm and felt even more tired, 24 hours after the vaccine she had a migraine lasting about 12 hours, 2.5 weeks after the vaccine she still struggled with fatigue, vertigo/dizziness, "foggy" headed feeling, and joint pain. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event migraine was resolved after 12 hours on an unknown date in Apr2021; while that of the events began to feel weak, foggy headed, sore arm, tired / struggle with fatigue, vertigo, dizziness and joint pain were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
High Temperature up to 103.7, Extreme Fatigue, Nausea/Vomiting, Feeling Very Weak, Dizziness, Extreme Headache, Very sore area where I got the shot. Hard knot, with a little blister that popped.
Patient was given 2nd Menactra vaccine. First vaccine was not on client record.  No reaction.
Eight days after the first vaccine, I woke up and my left arm was itchy and sore again. My arm was also visibly swollen. I developed a rash throughout the day that spread to approximately 3-4 inches in diameter where I received the vaccine. The rash lasted 48 hours and gradually faded. The injection site still itches and is sore to the touch.
I received the Pfizer Bivalent booster for COVID-19 on 9/15/2022; this was my third booster. On 11/16/2022, I ran a low-grade fever overnight. I also had sneezing and a runny nose. On 11/17/2022, I took a home antigen test and got a positive result. I called my PCP to ask him to prescribe me PAXLOVID, which he did. Later that evening, I developed a severe sore throat. It went away after a couple of days. Ever since then, I've been fine.
High fever, chills, severe joint pain, moderate to severe muscle pain, headache, nausea, diarrhea, swollen lymph node in left axilla, fatigue, weakness
Unfortunately we did use this beyond the use date of 10/9/21.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Unfortunately we did use this beyond the use date of 10/9/21.) in a 79-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Unfortunately we did use this beyond the use date of 10/9/21.). On 15-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Unfortunately we did use this beyond the use date of 10/9/21.) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was given.  No treatment medication was given.
A few hours after the shot, my throat felt like it had something stuck in it.  I tried everything to clear it, but it took several hours to go away.  It felt like my throat was closing up, however, it wasn't and it did pass.
small blisters; itch all over my body; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 18Apr2021 at 11:15 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic bronchitis on an unspecified date. Concomitant medications included vitamin d nos (VITAMIN D), zinc (MANUFACTURER UNKNOWN), acetylcysteine (N-ACETYL-L-CYSTEINE), cannabidiol (MANUFACTURER UNKNOWN) all from an unknown date for an unspecified indication. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 19Mar2021 at 17:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 08:00 the patient experienced small blisters that itch all over her body. The clinical outcome of the events blister, itching was not recovered.   No follow-up attempts are needed. No further information is expected.
left eye pulsating intermittently; 1st left side of face numb in spots. Now experiencing entire face with 'pins and needles' numbness intermittently; 1st left side of face numb in spots. Now experiencing entire face with 'pins and needles' numbness intermittently; This is a spontaneous report from a contactable nurse (patient). An adult female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL32495121), via an unspecified route of administration in the left arm on 14Jan2021 07:00 at a single dose for COVID-19 immunization. There were no medical history. The patient was not pregnant at the time of vaccination. Concomitant medication included loratadine, pseudoephedrine sulfate (CLARITIN-D). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. On 15Jan2021 09:30, the patient experienced her left eye was pulsating intermittently. First, the left side of face was numb in spots. Now, she experiencing entire face with pins and needles and numbness intermittently. No treatment was received for the adverse events. Outcome of the events was not recovered.
Mother stated that day care called her and said her child had spots on her abdomen, mother was told by nurse she could bring the child in to be looked at by the nurse practitioner. Mother said okay but she never came in. Mother was called back 9/6/01. No results due to unlisted number.
On 1st left arm red, seen on day 3 after  immunization slight erythema and induration 2.7 cm upper arm indurated.
dies after collapsing on the field; Initial information received on 27-Jan-2022 regarding an unsolicited valid Social Media serious case received from a consumer/non-hcp.  This case involves a 18 years old and unknown gender patient who experienced dies after collapsing on the field while receiving vaccine Influenza Vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect Influenza Vaccine produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for immunization.  On an unknown date the patient developed a serious event dies after collapsing on the field (circulatory collapse) (unknown latency) following the administration of Influenza Vaccine.   It was reported that  It goes on and on, and on.. it's happening everywhere, and is not normal. 18 year old dies after collapsing on the field.  Action taken : not applicable.  Corrective treatment : No corrective treatment reported for the event.  Event Outcome : At time of reporting, the outcome was Fatal for the event dies after collapsing on the field. It is unknown if an autopsy was done. The cause of death was reported as Death NOS.  Seriousness criteria : This event was assessed as medically significant and was leading to death. Final diagnosis was (fatal) dies after collapsing on the field.; Sender's Comments: Sanofi company comment dated 04-Feb-2022. This case involves a 18 years old and unknown gender patient who experienced dies after collapsing on the field while receiving Influenza Vaccine. Based on the limited information provided regarding this case, causal role of the company suspect product cannot be excluded. Case will be re-evaluated post further update on the patient's underlying disease conditions, past medical and drug history, concurrent illnesses, and concomitant medications.; Reported Cause(s) of Death: Unknown
Patient reported feeling nausea and dizziness post vaccination.  She began vomiting.  Offered oral hydration but patient unable to tolerate.  BP 95/57, HR 52, and O2 99% on room air.  Patient reported severe dizziness with standing.  Transported to ED for further evaluation.
Thinking I was having a stroke; I collapsed to the floor and could not get up for 10 minutes.; I had no response from my legs or arms or hands; This is a spontaneous report from a contactable consumer (patient). A 72-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date was not reported) via an unspecified route of administration, administered in Arm Right on 06Apr2021 at 12:00 (at the age of 71 years old) as DOSE 1, SINGLE for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included Cancer from an unknown date and unknown if ongoing, Known allergies: sulpha from an unknown date and unknown if ongoing. Concomitant medication(s) included alprazolam (ALPRAZOLAM) taken for an unspecified indication, start and stop date were not reported; sertraline (SERTRALINE) taken for an unspecified indication, start and stop date were not reported; hydrochlorothiazide (HYDROCHLOROTHIAZIDE) taken for an unspecified indication, start and stop date were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. The patient had not received any other vaccine within 4 weeks. List of other medications the patient received within 2 weeks of vaccination was Alprazolam, Sertraline, Hydrochlorothiazide. The reporter reported that, 2 weeks after first dose (on 20Apr2021 16:00), I collapsed to the floor and could not get up for 10 minutes. I had no response from my legs or arms or hands. I layed on the floor for 10 minutes, thinking I was having a stroke, and got up with no problem after 10 minutes. Was checked at the drs afterward and EKG was fine. The same happened on 02Nov2021. I fell to the floor and couldn't get up for approx. 10 minutes. The case was assessed as non-serious by the reporter. The patient was not hospitalized for the events. The events resulted in doctor or other healthcare professional office/clinic visit. No treatment was received for the events (thinking I was having a stroke and I had no response from my legs or arms or hands). The patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date was not reported) via an unspecified route of administration, administered in Arm Right on 29Apr2021 at 10:45, as DOSE 2, SINGLE for covid-19 immunisation. The patient underwent lab tests and procedures which included electrocardiogram which results as fine on unspecified date of 2021, sars-cov-2 test (Nasal Swab) which results negative on 28Oct2021. The outcome for the events thinking I was having a stroke and I had no response from my legs or arms, or hands was recovering and for the event I collapsed to the floor and could not get up for 10 minutes was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
This case was reported by a healthcare professional and described the occurrence of hepatitis b surface antigen positive in an adult female subject who was vaccinated with Engerix B for prophylaxis.  Concurrent medical conditions included dialysis and penicillin allergy.  Concurrent medications included Multiple unspecified medications.  On 13 February 2007 the subject received the 1st dose of Engerix B (40 mcg, unknown, unknown arm).  On 15 February 2007, 2 days after vaccination with Engerix B, blood work was completed, and the subject was found to be hepatitis b surface antigen positive.  Previously, the subject was hepatitis b surface antigen negative.  At the time of reporting the event was unresolved.  The healthcare professional considered the event was probably related to vaccination with Engerix B.
symptoms started 8/2/21 was tested negative for COVID  but got progressively worse with symptoms. Nasal drainage, ear pain, headache, cough
This spontaneous report as received from a registered nurse refers to a male patient of unknown age. The patient's current conditions or medical history were not reported. On an unknown date, the patient was vaccinated with 1 injection of VARIVAX (Merck) (dose, route, lot number and expiration date not reported). On an unknown date, reported as is being a long time, the reporter stated that the patient developed varicella like rash after being vaccinated with VARIVAX (Merck). Outcome of varicella like rash was unknown at the time of the report. Additional information has been requested.
11:37: felt rapid HR, c/o blurred vision & headache; 11:41: felt like might pass out, was assisted to floor; 11:43: HR: 85 BP: 135/90 O2: 100%, c/o blurred double vision, headache, & chest pain, & tongue swelling; 11:44 Benadryl 25 mg PO given; still c/o tongue swelling HR: 83; O2 applied at 25L via NC; 11:46: Rapid response team called; 11:48 18g IV started in LAC, Epinephrine 0.3 mg admin IV; 11:53: Slurred speech observed, c/o feeling tired; 11:56: BP: 155/100 HR:85 O2: 100% on O2 of 25L; 11:59: c/o chest pain, stated "tongue not as swollen"; 12:03: Pt alert & orientedx4 BP: 150/100 HR: 85 O2: 100% on 25L; 12:05: Pt on air mattress then transferred to stretcher; c/o Chest pain and dizziness; transferred to ED
Day after vaccine developed hives and angioedema of hands, forearms, feet and ankles and facial flushing - symptoms persist despite steroid therapy that began on 11-2-09 and seen again 11-5-09.  11/13/09:  Primary Care Records received from dates of service 11/2/09 to 11/5/09.  Angioedema, hives, possible allergic reaction to H1N1. Assessment:  Presents with painful, swollen area on hands , forearms, feet and ankles bilaterally.  Seen 3 days later with same and flushing of face.  Prednisone therapy begun on 11/2/09, Zyrtec added on 11/5.
right index finger became very stiff and I was unable to straighten it; knuckle of my right index finger became swollen and tender; knuckle of my right finger became tender; joint space narrowing; My finger continues to be sore; This is a spontaneous report from a contactable nurse (patient). A 38-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EN 6198; Expiration date were not reported), intramuscularly in the left arm on 27Feb2021 12:15 PM (at the age of 38-years-old) as first dose, single dose for COVID-19 immunisation at a hospital. Medical history included autonomic dysfunction, allergy to wasp, anaphylaxis (from allergy to wasp); all from an unknown date and unknown if ongoing. Concomitant medications included sertraline hydrochloride (ZOLOFT) and fludrocortisone; both taken for an unspecified indication, start and stop dates were not reported. The patient previously took cefalexin (KEFLEX) and ciprofloxacin (CIPRO) and experienced drug allergy. The patient was not pregnant at the time of vaccination. No other vaccine was received by the patient in four weeks. The patient had no COVID prior vaccination and was not tested for COVID post vaccination. On 04Mar2021 (reported as five days after receiving the vaccine), the patient experienced her right index finger became very stiff and was unable to straighten it, knuckle of her right index finger became swollen and tender, joint space narrowing (from the x-ray result) and her finger continues to be sore. The adverse events resulted in an urgent care visit. The patient underwent lab test and procedure which included X-ray:  normal except for some joint space narrowing on 04Mar2021. The patient was referred to ortho which has yet to be scheduled. Therapeutic measure with one dose of prednisone 5mg, which was prescribed by the patient's cardiologist, was taken as a result of the events. The outcome of the event finger continues to be sore was not recovered where it continues to be sore; outcome of the other events was recovering. It was reported that the patient was able to straighten her finger again and slightly stiff but is improving.  No follow-up attempts are possible. No further information is expected.